摩熵化学
数据开放平台 数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2E,5Z)-2-[(5-chloro-2-methylphenyl)imino]-5-{[1-(4-hydroxyphenyl)-1H-pyrrol-2-yl]methylidene}-1,3-thiazolidin-4-one

中文名称
——
中文别名
——
英文名称
(2E,5Z)-2-[(5-chloro-2-methylphenyl)imino]-5-{[1-(4-hydroxyphenyl)-1H-pyrrol-2-yl]methylidene}-1,3-thiazolidin-4-one
英文别名
(5Z)-2-(5-chloro-2-methylphenyl)imino-5-[[1-(4-hydroxyphenyl)pyrrol-2-yl]methylidene]-1,3-thiazolidin-4-one
(2E,5Z)-2-[(5-chloro-2-methylphenyl)imino]-5-{[1-(4-hydroxyphenyl)-1H-pyrrol-2-yl]methylidene}-1,3-thiazolidin-4-one化学式
CAS
——
化学式
C21H16ClN3O2S
mdl
——
分子量
409.9
InChiKey
ANALGJDPODAEQV-UNOMPAQXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    28
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.05
  • 拓扑面积:
    91.9
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation
    申请人:Universität Bern
    公开号:EP2952188A1
    公开(公告)日:2015-12-09
    The invention relates to a compound comprising the following general formula (1) for use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation: wherein each of R1, R2 and R3 are selected independently from each other from alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, aryl, heterocycle or heteroaryl.
    本发明涉及一种由以下通式(1)组成的化合物,用于治疗精神或神经疾病和炎症,尤其是神经炎症: 其中 R1、R2 和 R3 各自独立地选自烷基、烷氧基、烯基、炔基、环烷基、芳基、杂环或杂芳基。
  • THIAZOLIDINONES AS CELLULAR ANANDAMIDE UPTAKE INHIBITORS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION
    申请人:UNIVERSITÄT BERN
    公开号:US20170296515A1
    公开(公告)日:2017-10-19
    The invention relates to a compound comprising the following general formula (1) for use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation: (1) wherein each of R1, R2 and R3 are selected independently from each other from alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, aryl, heterocycle or heteroaryl.
  • [EN] THIAZOLIDINONES AS CELLULAR ANANDAMIDE UPTAKE INHIBITORS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION<br/>[FR] THIAZOLIDINONES EN TANT QU'INHIBITEURS D'ABSORPTION D'ANANDAMIDE CELLULAIRE ET LEUR UTILISATION DANS LE TRAITEMENT DE TROUBLES PSYCHIATRIQUES OU NEUROLOGIQUES ET DE L'INFLAMMATION, EN PARTICULIER LA NEURO-INFLAMMATION
    申请人:UNIVERSITÄT BERN
    公开号:WO2015181336A1
    公开(公告)日:2015-12-03
    The invention relates to a compound comprising the following general formula (1) for use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation: (1) wherein each of R1, R 2 and R 3 are selected independently from each other from alkyl, alkoxy, alkenyl,alkynyl,cycloalkyl, aryl,heterocycle or heteroaryl.
查看更多